The second is the evidence gap : because the blend has never been trialed as a fixed product, every dose, schedule and timeline here is inference from the two component literatures, not a proven blend outcome
The outcome of this process will have real, practical consequences for how providers can legally prescribe these compounds
Emerging evidence suggests that microglia, as key neuroimmune modulators within the CNS, influence the incidence and progression of cardiovascular diseases, including hypertension, myocardial infarction, and ischemia/reperfusion injury, through mechanisms potentially linked to altered autonomic nervous system activity (Wang M
[10] Diabetes Obesity & Metabolism (2024) NNMT inhibition mitigates obesity-linked metabolic imbalance and liver pathology (translational perspective)
Kokkoris S, Andrews P, Webb DJ